High-Priced Drugs in Medicare Part D : Diagnosis and Potential Prescription
Year of publication: |
2018
|
---|---|
Authors: | Frank, Richard G. |
Other Persons: | Zeckhauser, Richard J. (contributor) |
Publisher: |
[2018]: [S.l.] : SSRN |
Subject: | Effizienzmarkthypothese | Efficient market hypothesis | Arzneimittel | Pharmaceuticals | Gesetzliche Krankenversicherung | Public health insurance | Gesundheitsfinanzierung | Health care financing | Arzneimittelmarkt | Pharmaceutical market | Wettbewerb | Competition |
Extent: | 1 Online-Ressource (43 p) |
---|---|
Series: | NBER Working Paper ; No. w24240 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments January 2018 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
High-priced drugs in Medicare Part D : diagnosis and potential prescription
Frank, Richard G., (2018)
-
High-Priced Drugs in Medicare Part D : Diagnosis and Potential Prescription
Frank, Richard G., (2018)
-
The economics of alternative payment models for pharmaceuticals
Hlávka, Jakub P., (2021)
- More ...
-
Custom made versus ready to wear treatments : behavioral propensities in physician's choices
Frank, Richard G., (2007)
-
Custom-made versus ready-to-wear treatments : behavioral propensities in physicians' choices
Frank, Richard G., (2007)
-
Custom Made Versus Ready to Wear Treatments; Behavioral Propensities in Physician's Choices
Frank, Richard G., (2010)
- More ...